Gadoterate Meglumine SDS – CAS 92943-93-6 – Cleanchem
Original Cleanchem safety data sheet for Gadoterate Meglumine. Original PDF retained without modification. Source collected on 2026-09-13.
387 documents found
Original Cleanchem safety data sheet for Gadoterate Meglumine. Original PDF retained without modification. Source collected on 2026-09-13.
Original Cleanchem safety data sheet for Gadoteridol Impurity 6. Original PDF retained without modification. Source collected on 2026-09-13.
Original APExBIO safety data sheet for Gadoteridol. Original PDF retained without modification. Source collected on 2026-09-13.
Original Cayman Chemical safety data sheet for Gadoteridol. Original PDF retained without modification. Source collected on 2026-09-13.
Original MedChemExpress safety data sheet for Gadoteridol. Original PDF retained without modification. Source collected on 2026-09-13.
Original Sigma-Aldrich safety data sheet for Gadoteridol. Original PDF retained without modification. Source collected on 2026-09-13.
Original Ambeed safety data sheet for Gadoxetate disodium. Original PDF retained without modification. Source collected on 2026-09-13.
Original Ambeed safety data sheet for Gadoxetate disodium. Original PDF retained without modification. Source collected on 2026-09-13.
Collected by RESDS. Original publisher PDF retained. GADS-1 gadolinium isotopic CRM for laboratory use. SDS Section 3 lists nitric acid 2.0% (CAS 7697-37-2) and gadolinium oxide 0.1% (CAS 12064-62-9). Revision 26 August 2019, version 1.0. Source: National Research Council Canada. Licensed under the Open Government Licence – Canada.
Collected by RESDS. Original publisher PDF retained. GADS-1, matériau de référence certifié isotopique du gadolinium pour utilisation en laboratoire. La section 3 de la FDS indique 2,0 % d'acide nitrique (CAS 7697-37-2) et 0,1 % de trioxyde de digadolinium (CAS 12064-62-9). Révision du 26 août 2019, version 1,0. Source : Conseil national de recherches Canada. Licence du gouvernement ouvert – Canada.
Collected by RESDS. Original publisher PDF retained. Radioactive monazite reference material containing cerium, lanthanum, praseodymium, neodymium and optional yttrium phosphates, with thorium and uranium phosphates and quartz listed in Section 3. Original 17-page SDS revised 24 June 2020. U.S. Department of Energy government information; republished with acknowledgement under DOE web policy: https://www.energy.gov/web-policies
Collected by RESDS. Original publisher PDF retained. Earlier official revision of the radioactive monazite reference-material SDS. Section 3 lists cerium, lanthanum, praseodymium, neodymium and optional yttrium phosphates, plus thorium and uranium phosphates and quartz. Created 29 July 2011 and revised 08 October 2014. U.S. Department of Energy government information; republished with acknowledgement under DOE web policy: https://www.energy.gov/web-policies
Collected by RESDS. Original publisher PDF retained. Mineral sands concentrate used as raw material for rare-earth compounds. Section 3 is a multi-mineral mixture; CAS numbers and composition are retained only as stated by the original SDS. Revision 4 October 2022. Source: RZ Resources Ltd. Publication authorization confirmed by the RESDS site owner on 14 September 2026.
Original Bracco safety data sheet for MultiHance (CAN). Original PDF retained without modification. Source collected on 2026-09-13.
Original Lorad safety data sheet for Praseodymium-doped gadolinium oxysulfide. Original PDF retained without modification. Source collected on 2026-09-13.
Original Bracco safety data sheet for ProHance - Gadoteridol injection. CAS entries are substances/components identified in the original SDS: 7732-18-5; 120066-54-8; 77-86-1. Original PDF retained without modification. Source collected on 2026-09-13.
Original Bracco safety data sheet for ProHance - Gadoteridol injection. CAS entries are substances/components identified in the original SDS: 120066-54-8; 121915-83-1; 77-86-1. Original PDF retained without modification. Source collected on 2026-09-13.
Collected by RESDS. Original publisher PDF retained. Original manufacturer safety data sheet for Samarium (II) iodide, 0.1M in THF. Product number: ALFAA22360. Original revision: 03-Aug-2026. Published under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
Collected by RESDS. Original publisher PDF retained. Original ProChem SDS for Samarium (III) Acetate Hydrate. Product number 3073; revision 08/14. Publication authorized by the user on 2026-09-14.
Collected by RESDS. Original publisher PDF retained. Original ProChem SDS for Samarium (III) Acetate Hydrate. Product number 3074; revision 08/14. Publication authorized by the user on 2026-09-14.
Collected by RESDS. Original publisher PDF retained. Original ProChem SDS for Samarium (III) Acetylacetonate Hydrate. Product number 3103; revision 05/15. Publication authorized by the user on 2026-09-14.
Collected by RESDS. Original publisher PDF retained. Original manufacturer safety data sheet for Samarium (III) bromide. Product number: ALFAA14603. Original revision: 31-Jul-2026. Published under the file-level authorization confirmed by the user for the frozen 1,125-file manifest.
Collected by RESDS. Original publisher PDF retained. Original ProChem SDS for Samarium (III) Bromide, hexahydrate. Product number 3077; revision 08/14. Publication authorized by the user on 2026-09-14.
Collected by RESDS. Original publisher PDF retained. Original ProChem SDS for Samarium (III) Bromide, hexahydrate. Product number 3076; revision 08/14. Publication authorized by the user on 2026-09-14.